These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9378961)

  • 1. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
    Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
    J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
    Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
    Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
    Franciszkiewicz K; Le Floc'h A; Jalil A; Vigant F; Robert T; Vergnon I; Mackiewicz A; Benihoud K; Validire P; Chouaib S; Combadière C; Mami-Chouaib F
    Cancer Res; 2009 Aug; 69(15):6249-55. PubMed ID: 19638592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the mucosal integrin alpha(E)(CD103)beta(7) in tissue-restricted cytotoxicity.
    Smyth LJ; Kirby JA; Cunningham AC
    Clin Exp Immunol; 2007 Jul; 149(1):162-70. PubMed ID: 17403056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
    Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
    Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the epithelial cell-specific integrin, CD103, by human CD8+ cytolytic T lymphocytes.
    Hadley GA; Rostapshova EA; Gomolka DM; Taylor BM; Bartlett ST; Drachenberg CI; Weir MR
    Transplantation; 1999 Jun; 67(11):1418-25. PubMed ID: 10385079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal allograft rejection: the contribution of chemokines to the adhesion and retention of alphaE(CD103)beta7 integrin-expressing intratubular T cells.
    Al-Hamidi A; Pekalski M; Robertson H; Ali S; Kirby JA
    Mol Immunol; 2008 Sep; 45(15):4000-7. PubMed ID: 18649941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.
    Ericsson A; Svensson M; Arya A; Agace WW
    Eur J Immunol; 2004 Oct; 34(10):2720-9. PubMed ID: 15368288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
    Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice.
    Schön MP; Arya A; Murphy EA; Adams CM; Strauch UG; Agace WW; Marsal J; Donohue JP; Her H; Beier DR; Olson S; Lefrancois L; Brenner MB; Grusby MJ; Parker CM
    J Immunol; 1999 Jun; 162(11):6641-9. PubMed ID: 10352281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant donor CD103+CD8+ T cell infiltration into the gut epithelium during acute GvHD: a role of gut lymph nodes.
    Zhou S; Ueta H; Xu XD; Shi C; Matsuno K
    Int Immunol; 2008 Mar; 20(3):385-94. PubMed ID: 18303011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen-induced regulatory CD8+CD103+ T cells.
    Koch SD; Uss E; van Lier RA; ten Berge IJ
    Hum Immunol; 2008 Nov; 69(11):737-44. PubMed ID: 18822329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CD103 expression by CD8+ T cells responding to renal allografts.
    Wang D; Yuan R; Feng Y; El-Asady R; Farber DL; Gress RE; Lucas PJ; Hadley GA
    J Immunol; 2004 Jan; 172(1):214-21. PubMed ID: 14688328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin enhances the number of alloantigen-induced human CD103+CD8+ regulatory T cells in vitro.
    Uss E; Yong SL; Hooibrink B; van Lier RA; ten Berge IJ
    Transplantation; 2007 Apr; 83(8):1098-106. PubMed ID: 17452901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection.
    Hadley GA; Charandee C; Weir MR; Wang D; Bartlett ST; Drachenberg CB
    Transplantation; 2001 Nov; 72(9):1548-55. PubMed ID: 11707744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of interleukin 12 and interleukin 10 on superantigen-induced expression of cutaneous lymphocyte-associated antigen (CLA) and alphaEbeta7 integrin (CD103) by CD8+ T cells.
    Sigmundsdóttir H; Johnston A; Gudjónsson JE; Valdimarsson H
    Clin Immunol; 2004 Apr; 111(1):119-25. PubMed ID: 15093560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.